These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 25429991)
21. The flat-funding years and the National Cancer Institute: consequences for cancer research. Hitt E Mol Oncol; 2008 Dec; 2(4):290-2. PubMed ID: 19383350 [TBL] [Abstract][Full Text] [Related]
22. New president, new congress..... new hope for science? Wolinetz CD Physiologist; 2009 Feb; 52(1):1, 3-5. PubMed ID: 19271423 [No Abstract] [Full Text] [Related]
23. The toolbox is open, but who should pay for the job? Ladbury JE; Hall A; Skidmore J Nat Rev Drug Discov; 2014 Jul; 13(7):479-80. PubMed ID: 24981345 [No Abstract] [Full Text] [Related]
24. Border-wall dollars would double US cancer-research budget. DeCoursey TE Nature; 2019 Apr; 568(7750):33. PubMed ID: 30940965 [No Abstract] [Full Text] [Related]
25. The solid progress of nanomedicine. Martins JP; das Neves J; de la Fuente M; Celia C; Florindo H; Günday-Türeli N; Popat A; Santos JL; Sousa F; Schmid R; Wolfram J; Sarmento B; Santos HA Drug Deliv Transl Res; 2020 Jun; 10(3):726-729. PubMed ID: 32141035 [TBL] [Abstract][Full Text] [Related]
26. Basic biomedical research and the public's health cost...time...focus. Fitzgerald RS Physiologist; 2007 Feb; 50(1):1, 3-4. PubMed ID: 17366939 [No Abstract] [Full Text] [Related]
27. US Alzheimer's disease researchers feel the pinch. Williams R Lancet Neurol; 2011 May; 10(5):408-9. PubMed ID: 21511195 [No Abstract] [Full Text] [Related]
28. "The Good Old R01": Challenging Downward Funding Success Trends at the National Heart, Lung, and Blood Institute. Oh YS; Robinson V; Stanley DV; Tolunay E; Kim DY; Galis ZS Circ Res; 2016 May; 118(10):1475-9. PubMed ID: 27174948 [TBL] [Abstract][Full Text] [Related]
29. Assessing the value of America's investment in medical research. Hunt N MedGenMed; 2003 Jan; 5(1):34. PubMed ID: 12827095 [No Abstract] [Full Text] [Related]
30. The pathway to commercialization for nanomedicine. Flynn T; Wei C Nanomedicine; 2005 Mar; 1(1):47-51. PubMed ID: 17292057 [TBL] [Abstract][Full Text] [Related]
31. Is smaller better? Wallner PE J Am Coll Radiol; 2004 Dec; 1(12):904-5. PubMed ID: 17411730 [No Abstract] [Full Text] [Related]
32. The NCI Alliance for Nanotechnology in Cancer: achievement and path forward. Ptak K; Farrell D; Panaro NJ; Grodzinski P; Barker AD Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):450-60. PubMed ID: 20552623 [TBL] [Abstract][Full Text] [Related]
33. From progress to regression: biomedical research funding. Mandel HG; Vesell ES J Clin Invest; 2004 Oct; 114(7):872-6. PubMed ID: 15467821 [TBL] [Abstract][Full Text] [Related]
34. Academic medicine in turbulent times. Conroy JM J Med Pract Manage; 2013; 28(4):232-5. PubMed ID: 23547497 [TBL] [Abstract][Full Text] [Related]
38. NIH and NCI support for development of novel therapeutics in gynecologic cancer: a user's guide. Minig L; Trimble EL; Birrer MJ; Kim KY; Takebe N; Abrams JS Gynecol Oncol; 2010 Feb; 116(2):177-80. PubMed ID: 19889449 [TBL] [Abstract][Full Text] [Related]
39. The American Reinvestment and Recovery Act investment in comparative effectiveness research: lessons learned and implications for future investments. Dormer L; Greenfield S J Comp Eff Res; 2014 Nov; 3(6):559. PubMed ID: 25494558 [No Abstract] [Full Text] [Related]
40. National Cancer Institute's support of research to further integrative oncology practice. White JD J Natl Cancer Inst Monogr; 2014 Nov; 2014(50):286-7. PubMed ID: 25749590 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]